The Valley Desk

Clinical trial reportThe oncologistPublished

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The oncologist
Published
Subject terms
Humans; Rectal Neoplasms; Organoplatinum Compounds; Camptothecin; Fluorouracil; Leucovorin; Antineoplastic Combined Chemotherapy Protocols; Neoplasm Staging; Disease-Free Survival; Chemotherapy, Adjuvant; Quality of Life; Adult
PubMed ID
41397917
PubMed Central ID
PMC12795601
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal